These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21795772)

  • 1. Magnetic nanoparticle biodistribution following intratumoral administration.
    Giustini AJ; Ivkov R; Hoopes PJ
    Nanotechnology; 2011 Aug; 22(34):345101. PubMed ID: 21795772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An
    Giustini AJ; Ivkov R; Hoopes PJ
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810M. PubMed ID: 25301988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
    Dan M; Bae Y; Pittman TA; Yokel RA
    Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
    Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
    Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
    Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM
    Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease.
    Alphandéry E
    Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
    Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
    J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamical Magnetic Response of Iron Oxide Nanoparticles Inside Live Cells.
    Cabrera D; Coene A; Leliaert J; Artés-Ibáñez EJ; Dupré L; Telling ND; Teran FJ
    ACS Nano; 2018 Mar; 12(3):2741-2752. PubMed ID: 29508990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.
    Hoopes P; Strawbridge R; Gibson U; Zeng Q; Pierce Z; Savellano M; Tate J; Ogden J; Baker I; Ivkov R; Foreman A
    Proc SPIE Int Soc Opt Eng; 2007 Feb; 6440():64400K. PubMed ID: 25301985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats.
    Hannon G; Bogdanska A; Keogh A; Finn SP; Gobbo OL; Prina-Mello A
    Nanotoxicology; 2023 Dec; 17(8-9):562-580. PubMed ID: 37982374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
    ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.
    Salimi M; Sarkar S; Fathi S; Alizadeh AM; Saber R; Moradi F; Delavari H
    Int J Nanomedicine; 2018; 13():1483-1493. PubMed ID: 29559777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
    Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
    Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Iron Oxide Nanoparticle and Waterbath Hyperthermia Cytotoxicity.
    Ogden J; Tate J; Strawbridge R; Ivkov R; Hoopes P
    Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810K. PubMed ID: 25301987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
    Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
    Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.